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This review summarizes the latest advances in knowledge on the effects of flavonoids on
renal function in health and disease. Flavonoids have antihypertensive, antidiabetic, and
antiinflammatory effects, among other therapeutic activities. Many of them also exert
renoprotective actions that may be of interest in diseases such as glomerulonephritis,
diabetic nephropathy, and chemically-induced kidney insufficiency. They affect several
renal factors that promote diuresis and natriuresis, which may contribute to their
well-known antihypertensive effect. Flavonoids prevent or attenuate the renal injury
associated with arterial hypertension, both by decreasing blood pressure and by acting
directly on the renal parenchyma. These outcomes derive from their interference with
multiple signaling pathways known to produce renal injury and are independent of their
blood pressure-lowering effects. Oral administration of flavonoids prevents or ameliorates
adverse effects on the kidney of elevated fructose consumption, high fat diet, and
types I and 2 diabetes. These compounds attenuate the hyperglycemia-disrupted renal
endothelial barrier function, urinary microalbumin excretion, and glomerular hyperfiltration
that results from a reduction of podocyte injury, a determinant factor for albuminuria
in diabetic nephropathy. Several flavonoids have shown renal protective effects against
many nephrotoxic agents that frequently cause acute kidney injury (AKI) or chronic kidney
disease (CKD), such as LPS, gentamycin, alcohol, nicotine, lead or cadmium. Flavonoids
also improve cisplatin- or methotrexate-induced renal damage, demonstrating important
actions in chemotherapy, anticancer and renoprotective effects. A beneficial prophylactic
effect of flavonoids has been also observed against AKI induced by surgical procedures
such as ischemia/reperfusion (I/R) or cardiopulmonary bypass. In several murine models
of CKD, impaired kidney function was significantly improved by the administration of
flavonoids from different sources, alone or in combination with stem cells. In humans,
cocoa flavanols were found to have vasculoprotective effects in patients on hemodialysis.
Moreover, flavonoids develop antitumor activity against renal carcinoma cells with no
toxic effects on normal cells, suggesting a potential therapeutic role in patients with renal
carcinoma.
Keywords: kidney function, acute kidney injury, chronic kidney disease, flavonoids, nephroprotection, diabetes
mellitus, arterial hypertension
Vargas et al. Flavonoids as Renoprotective Agents
INTRODUCTION
Renal disorders are among the most common diseases. Acute
kidney injury (AKI) is associated with a greater long-term risk
of cardiovascular disease (CVD) and chronic kidney disease
(CKD) (Van Berendoncks et al., 2010). There is a lack of
effective treatment against CKD, which is increasingly prevalent
worldwide and related to a higher likelihood of CVD and death
(Coresh et al., 2007). There is therefore major clinical and social
interest in the development of therapies to treat renal disorders.
The present review addresses the effects of flavonoids on renal
physiology and their renoprotective effects in nephropaties of
different origin.
The term flavonoids refers to thousands of plant compounds
with a common basic structure, phenylchromane, which allows
the generation of multiple flavonoid subclasses (Figure 1)
including flavonols, flavones, catechins, anthocyanidins,
isoflavones, dihydroflavonols, and chalcones (Middleton et al.,
2000). Variable amounts of these compounds are found in
vegetables, fruits, nuts, spices, herbs, red wine and tea, among
others (Williams et al., 2004). Flavonoids are one of the main
classes of polyphenols, which have numerous pharmacological
activities, exert antioxidant effects (Middleton et al., 2000;
Manach et al., 2004), and are known to promote cardiovascular
health, but less is known about their role in renal function and
disease. We provide an update on knowledge of the effects
of flavonoids on renal function and the action mechanisms
involved, especially in relation to the most frequent acute and
chronic nephropathies encountered in clinical practice. We also
review preclinical data on the protective effect of flavonoids
against renal fibrosis and on their anti-tumor activity.
RENAL PHYSIOLOGY
Quercetin downregulates the renal expression of epithelial Na+
channel (ENaC) in hypertensive Dahl salt-sensitive rats, and this
effect is associated with a reduction in systolic blood pressure
(Aoi et al., 2004). The ENaC plays a key role in the kidney,
regulating Na+ reabsorption in renal tubules, and quercetin
also stimulates the Na+-K+-2Cl− cotransporter 1 (NKCC1),
a key ion transporter regulating cytosolic Cl− concentration
(Marunaka, 2017). NKCC1 activation affects several body and
cellular functions, such as renal Na+ reabsorption, thereby
regulating the concentration and volume of extracellular fluid
(Figure 2). Renal Na,K-ATPase is an important regulator of
sodium homeostasis in the organism, and its activity is enhanced
in spontaneously hypertensive rats (SHRs). Mezesova et al.
(2010) reported that quercetin reduced Na,K-ATPase activity
Abbreviations: AKI, acute kidney injury; CKD, chronic kidney disease; CVD,
cardiovascular disease; CRP, C-reactive protein; DOCA-salt, deoxicorticosterone
acetate- salt; ENaC, epithelial Na+ channel; EMT, epithelial to mesenchymal
transition; GSH, glutathione; IL, interleukin; I/R, ischemia/reperfusion; JNK, janus
kinase; L-NAME, Nω- nitro-L-arginine methyl ester; LPS, lipopolysaccharide;
MAPK,mitogen-activated protein kinase; NKCC1, Na+-K+-2Cl− cotransporter 1;
NO, nitric oxide; NOS, nitric oxide synthase; ROS, reactive oxygen species; SHR,
spontaneously hypertensive rats; TBARS, thiobarbituric acid reactive substances;
STZ, streptozotocin; TLR-4, Toll-like receptor 4; TNF-α, tumor necrosis factor-α.
FIGURE 1 | Flavonoid classes, their main subclasses and typical sources.
and affinity to the sodium binding site in both normotensive
and hypertensive rats. de Almeida et al. (2017) observed
that nothofagin, a dihydrochalcone isolated from Leandra
dasytricha leaves, had diuretic, natriuretic and potassium-
sparing effects in both normotensive and hypertensive rats,
finding these effects to be associated with increased prostanoid
generation, muscarinic receptor activation, and antioxidant
properties. Polymethoxylated flavones extracted from Rubus
rosaefolius Sm. (Rosaceae) and orally administered to male
Wistar rats also demonstrated diuretic and natriuretic activity
(de Souza et al., 2017) related to prostaglandin production.
In summary, quercetin and other flavonoids appear to modify
several factors that increase water and sodium excretion,
decreasing blood volume, and these changes likely contribute
to their antihypertensive actions, besides their well-known
cardiovascular effects.
HYPERTENSIVE NEPHROPATHY
Arterial hypertension is associated with renal dysfunction and
is one of the main etiologies of renal disease in the developed
world. A key objective of the treatment of arterial hypertension,
besides the reduction in blood pressure, is renal protection.
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FIGURE 2 | Effects of quercetin on sodium transporters in kidney tubules affect sodium balance.
The antihypertensive effects of the flavonoid quercetin are well
documented in various animal models of hypertension by Duarte
and colleagues. In 2001, it was reported to reduce the elevated
blood pressure and renal hypertrophy of SHRs in parallel with
a reduction in their systolic blood pressure, with no changes in
WKY controls. These effects were attributed to the antioxidant
properties of the drug (Duarte et al., 2001), and the results were
later confirmed in other laboratories (Romero et al., 2010). In
the DOCA-salt rat model, dietary quercetin was found to reduce
systolic blood pressure and renal hypertrophy and improve
kidney glutathione transferase activity (Galisteo et al., 2004a),
potassium depletion, and oxidative stress (Galisteo et al., 2004b).
Hence, quercetin demonstrates not only antihypertensive but
also renal antioxidant properties in this model. Epicatechin
treatment for 5 weeks also prevented the increased systolic blood
pressure and the proteinuria of DOCA-salt rats and produced a
reduction in systemic oxidative stress and endothelin-1 markers
(Gómez-Guzmán et al., 2012). Similar effects on these variables
were observed after treatment with red wine polyphenols in
the same model of hypertension (Jiménez et al., 2007). Chronic
treatment with quercetin also reduced systolic blood pressure and
proteinuria in the two-kidney one-clip hypertension Goldblatt
model, while having no effect on control rats (García-Saura
et al., 2005). In the same model, Kaur and Muthuraman (2016)
found that rutin, a flavonoid glucoside, reduced blood pressure,
renal hypertrophy, plasma renin content, and tissue TBARS and
increased GSH levels.
The antihypertensive and renal protective effects of quercetin
have also been evaluated in the L-NAME model, with an
exhaustive analysis of the histological changes (Duarte et al.,
2002). Chronic NO synthesis inhibition induces not only high
blood pressure but also renal hypertrophy and proteinuria and
intense histological lesions of the kidney; these include hyaline
arteriopathy and vascular wall thickening, with a moderately
reduced lumen, and an increase in oxidative stress. Quercetin
strongly inhibited the hypertension induced by L-NAME
and prevented the renal hypertrophy, vascular lesions, and
proteinuria, suggesting that this flavonoid also has a protective
effect against renal injury caused by the chronic inhibition of NO
synthesis.
SHRs treated with a grape seed proanthocyanidin extract for
22 weeks exhibited a dose-dependent reduction in inflammatory
infiltration at the renal interstitium and a decrease in albuminuria
but failed to attenuate the increase in blood pressure (Wang
et al., 2015). However, Lan et al. (2015) reported that grape
seed proanthocyanidins had an anti-hypertensive effect in
DOCA-salt hypertensive rats, preventing renal injury as well
as improving proteinuria, renal hypertrophy, and renal fibrosis
and oxidative stress markers via attenuation of renal JNK and
p38 kinase activities. Another flavonoid, morin, was found to
bring hypertension and renal function markers/histopathology
findings to near-normal levels in DOCA-salt hypertensive rats
(Prahalathan et al., 2012).
In fructose-fed hypertensive rats, Palanisamy and
Venkataraman (2013) observed that genistein produced
beneficial effects by lowering blood pressure, preserving renal
ultrastructural integrity and promoting eNOS activation and NO
synthesis in renal cells.
Flavonoids have also been administered in combination
with calcium antagonists and angiotensin-converting enzyme-
inhibitors. Puerarin is an isoflavone found in a number
of plants and herbs, such as the root of pueraria (radix
puerariae). The combination of felodipine with puerarin
improved blood pressure and heart rate more effectively and
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enhanced protective effects against renal interstitial fibrosis in
renovascular hypertensive rats (Bai et al., 2013). In humans,
the effects of pycnogenol in combination with the angiotensin-
converting enzyme inhibitor ramipril have been evaluated in
hypertensive patients with early signs of renal dysfunction
(Cesarone et al., 2010). Their joint administration for 6 months
lowered albuminuria, serum creatinine, and C-reactive protein
and increased kidney cortical flow to a greater degree than
ramipril alone. The results of these two studies indicate that the
combination of flavonoids with classic antihypertensive drugs
may be a useful therapeutic approach, especially in patients with
uncontrolled hypertension.
This section has reported evidence that flavonoids prevent
or ameliorate renal injury associated with arterial hypertension.
The action mechanism may be secondary to the reduction
of blood pressure and to the well-known protective effects of
flavonoids in the vascular system. However, flavonoids may also
act directly on the renal parenchyma and interfere with signaling
pathways that can affect the development of renal injury (e.g.,
oxidative stress, inflammatory molecules, protein kinases, and
matrix metalloproteinases), regardless of their effects on blood
pressure.
OBESITY AND DIABETES
High fructose consumption has been associated with renal
alterations that play a role in CKD development. Prince et al.
(2016) reported that (-)-epicatechin given in the rat chow
diet of male Sprague Dawley rats prevented or ameliorated
the adverse effects of high fructose consumption (10% w/v
fructose in drinking water) for 8 weeks. Fructose-fed rats showed
proteinuria, decreases in nephrin, synaptopodin, and Wilms’
tumor transcription factor (WT1) in the renal cortex, and all
podocyte dysfunction indicators, associated with an increase in
oxidative stress markers, changes in NO synthase (NOS) activity
and expression, and an increase in pro-inflammatory factors.
All of these renal abnormalities were ameliorated by dietary
supplementation with (-)-epicatechin.
Immoderate fat accumulation causes both oxidative stress
and inflammation, which can induce kidney damage in obese
subjects. Eo et al. (2017) studied the renal protective effects
on high-fat diet obese mice of different dosages of ecklonia
cava polyphenol extract given by gavage for 12 weeks, finding
that its administration lowered inflammation and oxidative
stress. In addition, supplementation with this polyphenol extract
significantly up-regulated renal SIRT1, PGC-1α, and AMPK,
which are associated with renal energy metabolism, thereby
improving the aberrant renal energy metabolism induced by a
high-fat diet.
Diabetic nephropathy is a progressive kidney disease and is
the main microvascular complication in diabetes. It has been
reported that a central role in the progression of diabetic
nephropathy is played by oxidative stress, inflammation, and
fibrosis. Streptozotocin (STZ)-induced type 1 diabetes is the most
frequently usedmurinemodel in studies of diabetic nephropathy,
and its utilization has revealed several flavonoids that exert
important renoprotective effects by various mechanisms. Thus,
Tian et al. (2015) reported that diabetic nephropathy could
be ameliorated in STZ-induced diabetic rats by icariside II
treatment through an increase in endothelial cell contents and
downregulation of the TGF-β/Smad/CTGF signaling pathway
and oxidative stress levels. These beneficial effects appear to
be mediated by its antioxidant capacity and the recruitment
of endogenous EdU+ progenitor cells to the kidney tissue.
Malik et al. (2017) found that apigenin treatment attenuated
renal dysfunction, oxidative stress, and fibrosis in STZ-
induced diabetic rats and prevented MAPK activation, inhibiting
inflammation and apoptosis, with renal tissue histopathological
findings of a reduction in inflammation, collagen deposition, and
glomerulosclerosis.
The isoflavonoid puerarin, from the Chinese medicinal
herb Radix puerariae, protected against diabetic nephropathy
in STZ-induced diabetic mice (Xu et al., 2016), improving
blood urea nitrogen/serum creatinine, fasting blood glucose,
and 24 h urine protein levels as well as kidney tissue
damage, with a reduction in mitochondrial damage. The
authors (Xu et al., 2016) affirmed that puerarin exerts
its renal protection by attenuating the SIRT1/FOXO1
pathway.
Podocyte injuries (e.g., slit diaphragm effacement) are
associated with the presence of albuminuria in diabetic
nephropathy. Using a STZ-induced diabetic nephropathy mouse
model, Zhang et al. (2016) examined the effect of hyperoside,
the 3-O-galactoside of quercetin, on proteinuria and renal
damage at an early stage. They found that 30 mg/kg/day of
oral hyperoside for 4 weeks decreased urinary excretion of
microalbumin and glomerular hyperfiltration. Hyperoside also
improved glomerular mesangial matrix expansion, podocyte
process effacement, and slit diaphragm reduction, and it restored
nephrin and podocin levels in diabetic nephropathy mice. All
of these data indicate the beneficial effects of hyperoside against
renal damage and podocyte injury.
Naringenin, a flavonone most frequently obtained from
grapefruit, orange, or tomato peel/skin, ameliorated STZ-
induced diabetic rat renal impairment by downregulating TGF-
β1 and IL-1 through themodulation of oxidative stress (Roy et al.,
2016). Moreover, naringenin-treated diabetic rats revealed an
improved renal histology and a significant reduction in apoptotic
activity.
Flavonoids have also shown renoprotective effects in type 2
diabetic mice (Db/db). Thus, Db/db mice orally treated with the
leaf extract (150 mg/kg/day) of Moringa oleifera for 5 weeks
reduced the histopathological damage and the expression in
renal tissue of tumor necrosis factor-alpha (TNF-α), interleukin
(IL)-1β, IL-6, cyclooxygenase-2, and inducible NOS (Tang
et al., 2017). Epigallocatechin-3-gallate, extracted from green tea,
also reduced renal pathology alterations and delayed diabetic
kidney disease progression in diabetic db/db mice through the
suppression of hyperglycemia-induced oxidative stress (Yang
et al., 2016).
Damage to capillaries in the glomeruli is the first step in the
development of diabetic nephropathy. Endothelial dysfunction
is an early marker of diabetic CVD and may play a role in
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progressive diabetic nephropathy, while hyperglycemia-induced
endothelial hyperpermeability is crucial for this disease. Wang X.
et al. (2016) assessed the effects of rutin pretreatment in an in
vitro model of hyperglycemia-induced barrier dysfunction using
human renal glomerular endothelial cells. They reported the
prevention of hyperglycemia-disrupted renal endothelial barrier
function via the RhoA/ROCK signaling pathway through a
reduction in reactive oxygen species mediated by nuclear factor
E2-related factor-2 (Nrf2) activation (Wang X. et al., 2016).
In summary, the oral administration of flavonoids has been
found to counter the adverse renal effects in mice or rats of
high fructose consumption, high-fat diet, STZ-induced type1
diabetes, and type 2 diabetes (Db/db mice) and to prevent
hyperglycemia-disrupted renal endothelial barrier function.
These effects are associated with a reduction in oxidative
stress and pro-inflammatory factors which attenuated urinary
microalbumin excretion and glomerular hyperfiltration through
the improvement of podocyte injury. The latter considered an
important factor for the development of albuminuria in diabetic
nephropathy.
NEPHROTOXIC AGENTS
Severe AKI can be produced by sepsis in bacterium-infected
patients, especially in the intensive care setting, and various
flavonoids have been tested against lipopolysaccharide (LPS)-
induced renal inflammation. The water extract of Heterobathmia
diffusa, a flavonoid-rich herb used in traditional Chinese
medicine, has been shown to have a protective effect on this
inflammation in mice, inhibiting production of TNF-α, IL-
1β, IL-6, and monocyte chemoattractant protein (MCP)-1 and
enhancing IL-10 production in serum and tissues (Ye et al., 2015).
Male Sprague Dawley rats pretreated for 4 days with dietary
(-)-epicatechin prevented the adverse effects of LPS challenge
by inhibiting TLR4 upregulation and NO activation and the
resulting downstream events, such as NF-kB activation (Prince
et al., 2017). LPS-mediated nephrotoxicity was also reduced by
pre-treatment with luteolin, a bioactive flavonoid, through an
improvement in renal oxidant status and a reduction in NF-κB
activation and inflammatory and apoptotic factors (Xin et al.,
2016).
Nephrotoxicity is one of the main adverse effects of
chemotherapy with cisplatin, widely used as a first-line
drug against various solid cancers, involving the generation
of reactive oxygen species, inflammation, apoptotic pathway
stimulation and MAPK pathway activation. Histopathology
study showed that cisplatin treatment was responsible for severe
renal necrosis/degeneration, tubular hyaline casts, intertubular
hemorrhage, glomerular congestion/swelling, and leukocyte
infiltration of renal tissue, limiting its dosage and clinical
usefulness (Ma et al., 2017). It is therefore vital to develop anti-
cancer drugs that protect the kidney against toxicity. Several
flavonoids attenuate cisplatin-induced renal injury in rats and
mice, mitigating cisplatin-induced histopathologic alterations
and reducing the increases in serum creatinine and blood urea
nitrogen. Their mechanism of action involves several pathways
of the inflammatory cascade and oxidative perturbations (Tanabe
et al., 2012; Malik et al., 2015, 2016; Arab et al., 2016; Chao
et al., 2016; He et al., 2016; Hassan et al., 2017; Huang D. et al.,
2017; Huang Y. C. et al., 2017; Lee et al., 2017; Ma et al., 2017),
including: the downregulation of activated NF-κB p65 protein
expression and its downstream effectors (e.g., iNOS and TNF-α),
with restoration of the anti-inflammatory IL-10; and reductions
in phospho-NF-κB p65 and phospho-P38 MAPK activation and
Nrf2 expression in cisplatin-induced renal injury. Flavonoids also
downregulated the expression of the apoptotic marker caspase-
3, inhibiting cisplatin-induced apoptosis and thereby favoring
renal cell survival. Mouse studies have also revealed a reduction
in mitochondrial mass, oxidative phosphorylation complexes,
and superoxide dismutase levels in cisplatin nephropathy, which
was prevented by the administration of flavanol (-)-epicatechin
without modifying the anticancer effect of cisplatin in HeLa cells
(Tanabe et al., 2012). Besides offering renal protection against
cisplatin nephrotoxicity, some flavonoids have also demonstrated
antitumor activity. Thus, the cytotoxic actions of cisplatin in
Hep3B and HCT-116 human cancer cell lines were enhanced by
tangeretin (Arab et al., 2016), while COLO205 and HeLa tumor
cell growth was inhibited by puerarin, which dose-dependently
promoted the antitumor activity of cisplatin in these tumor
cells (Ma et al., 2017). Finally, a study in rats found that
methotrexate-induced renal damage, apoptosis, and oxidative
stress were ameliorated by quercetin (Erboga et al., 2015). It is
interesting to note that flavonoids may exert both anticancer and
renoprotective actions in chemotherapy.
Several other flavonoids have shown renal protective effects
against numerous nephrotoxic agents that frequently cause
acute or chronic kidney injury. The general and common
mechanism of action of flavonoids is their attenuation of renal
oxidative stress and inflammation. Flavonoids that have been
reported to protect rat or mouse kidney against nephrotoxic
agents include: flavocoxid (El-Kashef et al., 2015), pinocembrin
(Promsan et al., 2016), and gossypin (Katary and Salahuddin,
2017), which attenuated gentamicin-induced nephrotoxicity in
rats; trigonella foenum-graecum (TFG) seeds (Pribac et al.,
2015), which prevented cell deterioration and improved renal
morphology and function in the kidney of alcoholized rats;
hydroxyflavone and 7-hydroxyflavone, which protected against
nicotine-induced oxidative stress (Sengupta et al., 2017); baicalin,
which protected against lead-induced renal oxidative damage
in mice (Zhang et al., 2017); and epigallocatechin-3-gallate,
which attenuated cadmium-induced chronic renal injury/fibrosis
(Chen et al., 2016) and reduced contrast-induced renal injury
alone (Gao et al., 2016) or with glycerol-induced renal damage
(Palabiyik et al., 2017).
ISCHEMIA-REPERFUSION INJURY AND
OTHER SURGICAL PROCEDURES
A major cause of kidney failure is renal ischemia/reperfusion
(I/R) injury, which can occur in kidney transplantation, partial
nephrectomy, renal artery angioplasty, aortic aneurysm surgery,
and elective urological surgery, among others. I/R injury triggers
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a cascade of events that produce injury to renal cells and
their eventual death. Renal reperfusion injury is associated
with increased mortality and morbidity due to AKI. In rat
studies, renal I/R is usually associated with increased serum
creatinine, urea and uric acid, elevated diuresis and natriuresis
alongside impaired concentrating ability and reduced renal
superoxide dismutase, catalase, and glutathione activities. The
histopathological changes induced by I/R are characterized by
glomerular injury and extensive tubular damage, with signs of
tubular cell swelling, tubular dilatation, interstitial edema, and
moderate-to-severe necrosis (Bhalodia et al., 2009; Lin et al.,
2014; Zhao et al., 2016; Yang et al., 2017). Flavonoids and other
phytochemical compounds have shownmarked protective effects
against I/R-induced AKI, generally mediated by their antioxidant
and anti-inflammatory actions.
Diosmetin is a flavonoid glycoside that inhibits the renal
inflammatory response and cellular apoptosis (Yang et al.,
2017) and was found to protect against I/R-induced AKI
in mice by suppressing nuclear factor-κB and mitochondrial
apoptosis pathways and activating the nuclear factor erythroid
2-related factor 2/heme oxygenase-1 pathway. The traditional
Chinese herb root baicalin has been reported to protect
against renal I/R injury by inhibiting the production of
proinflammatory cytokines, including TNF-α and IL-1β (Lin
et al., 2014). Flavonoids from Rosa laevigata Michx fruit also
exerted nephroprotective effects against I/R AKI by suppressing
oxidative stress and inflammation, affecting the Sirt1/Nrf2/NF-
κB signaling pathway (Zhao et al., 2016). Other antioxidants that
have shown protective effects against I/R-induced renal damage
in rats include the extract of Benincasa cerifera fruit, widely
consumed in India and other tropical countries (Bhalodia et al.,
2009), and aqueous garlic extract, whose administration 15min
before ischemia and immediately before reperfusion decreased
I/R-induced injury in rat kidney (Kabasakal et al., 2005; Bagheri
et al., 2011). AKI induced by cardiopulmonary bypass was
found to be improved in diabetic rats by the preoperative oral
administration of epigallocatechin-3-gallate, a major component
of the polyphenolic fraction of green tea, thanks to its antioxidant
properties (Funamoto et al., 2016). This treatment has been
proposed for prophylactic renal protection against AKI after
cardiopulmonary bypass in the clinical setting, especially in high-
risk diabetic patients.
CHRONIC KIDNEY DISEASE
CKD is a major and increasing health problem worldwide, and
there is no effective treatment. Flavonoids from different sources,
alone or in combination with stem cells, have significantly
improved kidney function in several models of chronic renal
failure.
Daily doses for 8 weeks of icariin, a kidney-tonifying active
flavonoid component of the Epimedium plant species, widely
used in Chinese medicine, protected against renal function
impairment and histological abnormalities secondary to chronic
renal failure produced by 5/6 nephrectomy (Huang et al., 2015).
Icariin also reduced TGF-β1 expression, increased CD24, CD133,
Osr1, and Nanog expressions, and augmented the number
of CD133(+)/CD24(+) renal stem/progenitor cells, considered
responsible for these protective effects. In a later study (Figure 3),
administration of icariin combined with human umbilical cord
mesenchymal stem cells to rats with chronic kidney failure
improved the kidney function, reduced the oxidative damage,
inflammatory responses and fibrosis levels, and enhanced the
expression of growth factors (Li et al., 2017).
The multi-organ dysfunctions produced by systemic lupus
erythematosus generate a severe immune regulation disorder,
with autoantibody overproduction, lupus nephritis, aberrant
CD4+ T cell activation, and immune complex-mediated
inflammation. Quercitrin, a glycoside formed from the flavonoid
quercetin, diminished serum antibodies, reduced CD4+ T cell
activation, and ameliorated lupus nephritis symptoms in a
systemic lupus erythematosus mouse model (Li et al., 2016).
Liao et al. (2016) also reported that icaritin, an active extract
of the genus Epidemium used in traditional Chinese medicine,
inhibited the over-activation of CD4+ T cells from systemic
lupus erythematosus and improved renal damage in mice.
In a rat study Ali et al. (2016), the flavonoid chrysin, which
exerts strong antioxidant and anti-inflammatory activities, was
tested on adenine-induced CKD, administering doses of 10,
50, or 250 mg/kg 10 consecutive days after the consumption
of adenine (0.25%, w/w) for 35 days. Chrysin, especially at
250 mg/kg, mitigated all manifestations of adenine-induced
renal dysfunction, improved creatinine clearance, and reduced
concentrations of urea, creatinine, plasma neutrophil gelatinase-
associated lipocalin, urinary N-Acetyl-beta-D-glucosaminidase,
uremic toxin indoxyl sulfate, and some inflammatory cytokines.
Histopathological markers of renal inflammation and fibrosis
and renal oxidative stress were also improved.
Naringenin, a natural flavonoid with various biological and
pharmacological properties attenuated cardiac remodeling and
cardiac dysfunction in a rat model of cardiorenal syndrome
(Liu et al., 2016), improving renal function and reducing serum
creatinine, blood urea nitrogen, type-B natriuretic peptide,
aldosterone, angiotensin II, C-reactive protein, and urine protein
concentrations as well as decreasing ROS levels through an
increase in nuclear factor erythroid 2-related factor 2 expression.
Finally, a double-blind, randomized, placebo-controlled trial
in humans reported that dietary cocoa flavanols had a vascular
protective effect in patients on hemodialysis (Rassaf et al., 2016).
RENAL APOPTOSIS AND FIBROSIS
Apoptosis is an active response of cells to altered
microenvironments and is characterized by cell shrinkage,
chromatin condensation, and DNA fragmentation. In kidney
cells, apoptosis has been observed in renal epithelial cells,
endothelial cells, mesangial cells, and podocytes, among other
cell types. Hyperglycemia is among microenvironmental
factors that may facilitate apoptosis, which is a key trigger
of diabetic nephropathy. Mohan et al. (2017) explored the
capacity of epigallocatechin-3-gallate to prevent apoptosis
in rats on a high-fat diet and with STZ-induced diabetic
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FIGURE 3 | Icariin together with mesenchymal stem cells (MSCs) improve a rat model of CKD.
nephropathy, demonstrating an improvement in renal function
by the downregulation of TGF-β, ameliorating their diabetic
nephropathy. Baicalin, a flavonoid widely used to treat infectious
and inflammatory diseases, also inhibited renal cell apoptosis in
a mouse model of sepsis produced by cecal ligation and puncture
(Zhu et al., 2016) through inhibition of the pro-apototic regulator
BAX. Rats with gentamicin-induced kidney injury were also
protected from oxidative stress-induced apoptosis by aqueous
extracts of Rhizoma smilacis glabrae through inhibition of
proapoptotic caspase-3 activation (Liu et al., 2017).
Renal fibrosis plays an important role in the pathogenesis
of renal failure and in the progression of CKD. Epithelial
to mesenchymal transition (EMT) contributes to the renal
accumulation of matrix proteins and therefore to progressive
renal fibrosis. Flavonoids have demonstrated activity against
unilateral ureteral obstruction, 5/6 nephrectomy, hypertension,
and diabetes, among other nephropathies. Renal injury induced
by unilateral ureteral obstruction is frequently used in a rat model
of renal fibrosis, and Wang B. et al. (2016) found that daily oral
gavage (100mg/kg) for 2 weeks of rutin, a polyphenolic flavonoid,
ameliorated their kidney interstitial fibrosis, reducing renal
interstitial injury and suppressing interstitial collagen deposits.
Rutin decreased macrophage infiltration, proinflammatory
cytokine expression, and phosphorylation of nuclear factor-κB
p65 and inhibited extracellular matrix accumulation by reducing
type I/III collagen and fibronectin expressions. Rutin also
decreased α-smooth muscle actin expression and maintained
E-cadherin expression, preventing EMT in renal tubular cell. The
authors attributed these changes to anti-inflammatory action
and TGF-β1/Smad3 signaling inhibition. Rutin also improved
the proteinuria and renal oxidative stress in 5/6-nephrectomized
rats, reducing glomerulosclerosis and tubulointerstitial injuries
(Han et al., 2015). The treatment of mice with unilateral
ureteral obstruction using the isoflavone puerarin, found in a
number of plants and herbs such as the root of Pueraria (Radix
puerariae), reduced renal fibrosis through the inhibition of
oxidative stress induced-epithelial cell apoptosis via MAPK
signaling (Zhou et al., 2017). In this same model, intraperitoneal
administration of baicalin every 2 days for 10 days ameliorated
renal fibrosis and suppressed EMT via inhibition of TFG β1
production and Smad2/3 phosphorylation signaling (Zheng
et al., 2017).
Hypertension-induced renal fibrosis is an important factor in
the progression of hypertensive nephropathy. A 4-week course
of dietary apigenin, an anti-hypertensive flavone abundant in
celery, reduced DOCA-salt-induced structural and functional
kidney damage and fibrosis, with a reduction in the expressions of
TFG β1, the Smad2/3 signaling pathway, and extracellular matrix
proteins (Wei et al., 2017).
Kang et al. (2015) investigated the effects of chrysin (5,7-
dihydroxyflavone), found in herbs and bee propolis, on EMT
and tubulointerstitial fibrosis due to chronic hyperglycemia
in human renal proximal tubular epithelial cells. These were
incubated in media with high levels of glucose in the absence
and presence of 1–20µM chrysin for 72 h. Chrysin inhibited
the glucose-induced renal EMT, tubular cell production of
collagen and collagen fiber deposition. Taken together, the data
reported in this section indicate that several flavonoids possess
antifibrotic properties and that their main action mechanisms
are EMT inhibition and interference with TGF-β1/Smad
signaling.
RENAL CARCINOMA
Flavonoids have demonstrated action against several types
of cancer cells. Thus, apigenin exerts antitumor activity in
various cancers. An evaluation by Meng et al. (2017) of its
effects and action mechanisms in renal carcinoma cells found
that it induced DNA damage, G2/M phase cell cycle arrest,
p53 accumulation, and apoptosis, which together inhibited
ACHN RCC cell proliferation in vitro and in vivo. Apigenin
is a highly promising agent against renal carcinoma due to
these antitumor effects and low in vivo toxicity. Woo and
Kwon (2016) reported that jaceosidin, a flavonoid isolated
from artemisia vestita, exerted anti-tumor and anti-proliferative
activities in many cancer cells and produced apoptosis in
different human renal carcinoma cells (Caki, ACHN, A498,
and 786-O), with the activation of caspase-3 and cleavage of
poly (ADP-ribose) polymerase. This treatment also reduced
mitochondrial membrane potential and Bax activation, releasing
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cytochrome C into the cytosol. Interestingly, apoptosis was
not induced by Jaceosidin in normal human umbilical vein
cells.
In vitro and in vivo studies have demonstrated the anticancer
capabilities in renal cell carcinoma cells of silibinin, an
antioxidant flavonoid extracted frommilk thistle, which inhibited
renal cell carcinoma growth through caspase-dependent
apoptosis (Ma et al., 2015). In an in vivomouse xenograft model,
silibinin also reduced tumor growth, specifically targeting the
mTOR-GLI1-BCL2 signaling pathway.
Galangin, a flavonoid extracted from the root of Alpinia
officinarum was reported to possess antiproliferative action and
to inhibit renal cell carcinoma (786-0 and Caki-1) invasion
by suppressing EMT, inducing apoptosis and producing ROS
in renal carcinoma cells (Cao et al., 2016). Han et al.
(2016) observed that the combination of galangin and TRAIL
significantly induced apoptosis in renal carcinoma (Caki, ACHN,
and A498) but not in normal mouse kidney cells or human
normal mesangial cells, suggesting the potential utilization
of galangin as a sensitizer of TRAIL-resistant cancer cell
therapy. Meng et al. (2015) combined quercetin with anti-
sense oligo gene therapy (Snail gene inhibition) and found
that each suppressed the proliferation and migration of Caki-
2 cells, inducing cell cycle arrest and apoptosis, with a strong
suppression of renal carcinoma cells being achieved by their
combination. Their findings supported this combination of
natural product and gene therapy as a novel treatment for renal
cancer.
The above findings demonstrate that flavonoids develop
antitumor activity against renal carcinoma cells without
toxic effects on normal cells, suggesting their potential
value to treat renal carcinoma alone or in combination
(Figure 4).
UNDESIRABLE EFFECTS OF FLAVONOIDS
Green tea is a popular beverage with protective effects against
several renal diseases. Thus, polyphenols from this product
demonstrated protective activity against renal injury in lead-
exposed rats through ROS scavenging activity (Wang H. et al.,
2016) and against renal ischemia-reperfusion injury in rats (Lv
et al., 2015). They also protected diabetic rats against AKI
after cardiopulmonary bypass (Funamoto et al., 2016) and
attenuated high-fat diet-induced renal oxidative stress (Yang
et al., 2015), as well as showing hypouricemic effects (Chen
et al., 2015). However, despite its positive effects on these types
of kidney disease, green tea may also have undesirable effects
in chronic renal failure. Green tea is rich in catechins, which
are putative substrates of anion transporters such as OAT1
and OAT3. Chronic renal failure is associated with high levels
of indoxyl sulfate and p-cresyl sulfate, nephro-cardiovascular
toxins whose renal excretion is mediated by organic anion
transporters, and green tea intake was found to increase systemic
levels of endogenous indoxyl sulfate and p-cresyl sulfate and
levels of serum creatinine and blood urea nitrogen in rats
with adenine-induced chronic renal failure (Peng et al., 2015).
The authors concluded that green tea metabolites impair renal
function by inhibiting the uptake transporting functions of
OAT1 and OAT3, thereby reducing the elimination of nephro-
cardiovascular toxins.
CONCLUSIONS
The studies in this review demonstrate that flavonoids have
important effects on renal physiology and possess diuretic
and natriuretic properties, as well as exerting renoprotective
effects in AKI and CKD of different etiologies (Figure 5). Their
FIGURE 4 | Mechanisms through which flavonoids interfere with carcinogenesis mechanisms.
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FIGURE 5 | Flavonoids exert renoprotective actions due to their multiple beneficial properties, counteracting the deleterious effects of kidney injuries that can lead to
chronic kidney disease.
protective effects against the different nephropathies reviewed
indicate that their main mechanism of action is their impact on
the inflammatory cascade and oxidative perturbations, affecting
several pathways. Flavonoids also possess major antiapoptotic
and antifibrotic properties, inhibiting EMT and interfering with
TGF-β1/Smad signaling, which may play an essential role in
their renoprotective action in CKD. Various flavonoids also
develop antitumor activity in renal carcinoma cells, inducing
cell cycle arrest and apoptotic cell death via several pathways
and suppressing renal carcinoma cell proliferation in vitro and
in vivo. These antitumor effects are associated with scant toxicity
in normal cells.
PERSPECTIVES
CKD is a public health epidemic associated with an increased
risk of death and CVD, including uremic cardiomyopathy and
vascular calcification. This review of recent advances in our
understanding of the effects and actionmechanisms of flavonoids
show that they can attenuate the AKI induced by different
nephrotoxic agents and reduce renal fibrosis. These data support
the possible usefulness of these compounds as novel therapeutic
agents against chronic complications in patients, including CVD
in CKD. However, numerous methodological problems prevent
the drawing of exhaustive and clear conclusions on this issue,
which warrants considerable further research. The development
of new therapeutic strategies requires a greater understanding
of the cellular and molecular mechanisms underlying the effect
of flavonoids on CKD progression and CVD development.
There is a need to clearly establish and standardize the
composition of compounds in polyphenols in order to elucidate
and reproduce their therapeutic mechanisms of action. In
addition, it is important to identify themetabolites resulting from
their administration, which may also be responsible for their
effects. Translational investigations are also required to enhance
bench-to-bedside transition, exploring whether polyphenols
and flavonoids can become pharmacological agents of natural
origin to improve the treatment of cardiovascular and renal
diseases.
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